Discontinued
EDRONAX reboxetine 4mg (as mesilate) tablet blister pack
reboxetine mesilate · 5.224 mg Tablet, uncoated
- Deletion from market
- 16 Nov 2026
- TGA row last updated
- 22 Oct 2026
- ARTG ID
- 79745
- Sponsor
- Pfizer Australia Pty Ltd
- Sponsor phone
- 1800 675 229
- Shortage impact
- Low
- Availability
- Unavailable
Reason reported to TGA
Commercial Changes / Commercial viability
TGA management action
This product is being replaced by EDRONAX reboxetine 4mg (as mesilate) tablet bottle (ARTG 521130).
What to do
- 1.This product is discontinued in the TGA export — Ask your prescriber or pharmacist about a product that is still supplied. Do not stop treatment without that advice.
Official sources
Last updated from the TGA Medicine Shortage Reports Database (report generated 12 November 2026 10:15:07 PM).
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.